Human Platelet Lysate Maintains Stemness of Umbilical Cord-Derived Mesenchymal Stromal Cells and Promote Lung Repair in Rat Bronchopulmonary Dysplasia

Mesenchymal stromal cells (MSCs) show potential for treating preclinical models of newborn bronchopulmonary dysplasia (BPD), but studies of their therapeutic effectiveness have had mixed results, in part due to the use of different media supplements for MSCs expansion in vitro. The current study sou...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Guilian Liao, Yan Liao, Duanduan Li, Zeqin Fu, Shiduo Wu, Danling Cheng, Qiuxing Ouyang, Zan Tang, Guifang Zeng, Xiao Liang, Shaokun Xu, Junyuan Hu, Muyun Liu
Formato: article
Lenguaje:EN
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://doaj.org/article/fb120545559c4558ac642f985daec6df
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:fb120545559c4558ac642f985daec6df
record_format dspace
spelling oai:doaj.org-article:fb120545559c4558ac642f985daec6df2021-11-10T14:28:04ZHuman Platelet Lysate Maintains Stemness of Umbilical Cord-Derived Mesenchymal Stromal Cells and Promote Lung Repair in Rat Bronchopulmonary Dysplasia2296-634X10.3389/fcell.2021.722953https://doaj.org/article/fb120545559c4558ac642f985daec6df2021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fcell.2021.722953/fullhttps://doaj.org/toc/2296-634XMesenchymal stromal cells (MSCs) show potential for treating preclinical models of newborn bronchopulmonary dysplasia (BPD), but studies of their therapeutic effectiveness have had mixed results, in part due to the use of different media supplements for MSCs expansion in vitro. The current study sought to identify an optimal culture supplement of umbilical cord-derived MSCs (UC-MSCs) for BPD therapy. In this study, we found that UC-MSCs cultured with human platelet lysate (hPL-UCMSCs) were maintained a small size from Passage 1 (P1) to P10, while UC-MSCs cultured with fetal bovine serum (FBS-UCMSCs) became wide and flat. Furthermore, hPL was associated with lower levels of senescence in UC-MSCs during in vitro expansion compared with FBS, as indicated by the results of β-galactosidase staining and measures of senescence-related genes (CDKN2A, CDKN1A, and mTOR). In addition, hPL enhanced the proliferation and cell viability of the UC-MSCs and reduced their doubling time in vitro. Compared with FBS-UCMSCs, hPL-UCMSCs have a greater potential to differentiate into osteocytes and chondrocytes. Moreover, using hPL resulted in greater expression of Nestin and specific paracrine factors (VEGF, TGF-β1, FGF2, IL-8, and IL-6) in UC-MSCs compared to using FBS. Critically, we also found that hPL-UCMSCs are more effective than FBS-UCMSCs for the treatment of BPD in a rat model, with hPL leading to improvements in survival rate, lung architecture and fibrosis, and lung capillary density. Finally, qPCR of rat lung mRNA demonstrated that hPL-UCMSCs had lower expression levels of inflammatory factors (TNF-α and IL-1β) and a key chemokine (MCP-1) at postnatal day 10, and there was significant reduction of CD68+ macrophages in lung tissue after hPL-UCMSCs transplantation. Altogether, our findings suggest that hPL is an optimal culture supplement for UC-MSCs expansion in vitro, and that hPL-UCMSCs promote lung repair in rat BPD disease.Guilian LiaoYan LiaoDuanduan LiZeqin FuShiduo WuDanling ChengQiuxing OuyangZan TangGuifang ZengXiao LiangShaokun XuJunyuan HuMuyun LiuFrontiers Media S.A.articlemesenchymal stromal cellshuman platelet lysatebronchopulmonary dysplasiasenescencelung repairBiology (General)QH301-705.5ENFrontiers in Cell and Developmental Biology, Vol 9 (2021)
institution DOAJ
collection DOAJ
language EN
topic mesenchymal stromal cells
human platelet lysate
bronchopulmonary dysplasia
senescence
lung repair
Biology (General)
QH301-705.5
spellingShingle mesenchymal stromal cells
human platelet lysate
bronchopulmonary dysplasia
senescence
lung repair
Biology (General)
QH301-705.5
Guilian Liao
Yan Liao
Duanduan Li
Zeqin Fu
Shiduo Wu
Danling Cheng
Qiuxing Ouyang
Zan Tang
Guifang Zeng
Xiao Liang
Shaokun Xu
Junyuan Hu
Muyun Liu
Human Platelet Lysate Maintains Stemness of Umbilical Cord-Derived Mesenchymal Stromal Cells and Promote Lung Repair in Rat Bronchopulmonary Dysplasia
description Mesenchymal stromal cells (MSCs) show potential for treating preclinical models of newborn bronchopulmonary dysplasia (BPD), but studies of their therapeutic effectiveness have had mixed results, in part due to the use of different media supplements for MSCs expansion in vitro. The current study sought to identify an optimal culture supplement of umbilical cord-derived MSCs (UC-MSCs) for BPD therapy. In this study, we found that UC-MSCs cultured with human platelet lysate (hPL-UCMSCs) were maintained a small size from Passage 1 (P1) to P10, while UC-MSCs cultured with fetal bovine serum (FBS-UCMSCs) became wide and flat. Furthermore, hPL was associated with lower levels of senescence in UC-MSCs during in vitro expansion compared with FBS, as indicated by the results of β-galactosidase staining and measures of senescence-related genes (CDKN2A, CDKN1A, and mTOR). In addition, hPL enhanced the proliferation and cell viability of the UC-MSCs and reduced their doubling time in vitro. Compared with FBS-UCMSCs, hPL-UCMSCs have a greater potential to differentiate into osteocytes and chondrocytes. Moreover, using hPL resulted in greater expression of Nestin and specific paracrine factors (VEGF, TGF-β1, FGF2, IL-8, and IL-6) in UC-MSCs compared to using FBS. Critically, we also found that hPL-UCMSCs are more effective than FBS-UCMSCs for the treatment of BPD in a rat model, with hPL leading to improvements in survival rate, lung architecture and fibrosis, and lung capillary density. Finally, qPCR of rat lung mRNA demonstrated that hPL-UCMSCs had lower expression levels of inflammatory factors (TNF-α and IL-1β) and a key chemokine (MCP-1) at postnatal day 10, and there was significant reduction of CD68+ macrophages in lung tissue after hPL-UCMSCs transplantation. Altogether, our findings suggest that hPL is an optimal culture supplement for UC-MSCs expansion in vitro, and that hPL-UCMSCs promote lung repair in rat BPD disease.
format article
author Guilian Liao
Yan Liao
Duanduan Li
Zeqin Fu
Shiduo Wu
Danling Cheng
Qiuxing Ouyang
Zan Tang
Guifang Zeng
Xiao Liang
Shaokun Xu
Junyuan Hu
Muyun Liu
author_facet Guilian Liao
Yan Liao
Duanduan Li
Zeqin Fu
Shiduo Wu
Danling Cheng
Qiuxing Ouyang
Zan Tang
Guifang Zeng
Xiao Liang
Shaokun Xu
Junyuan Hu
Muyun Liu
author_sort Guilian Liao
title Human Platelet Lysate Maintains Stemness of Umbilical Cord-Derived Mesenchymal Stromal Cells and Promote Lung Repair in Rat Bronchopulmonary Dysplasia
title_short Human Platelet Lysate Maintains Stemness of Umbilical Cord-Derived Mesenchymal Stromal Cells and Promote Lung Repair in Rat Bronchopulmonary Dysplasia
title_full Human Platelet Lysate Maintains Stemness of Umbilical Cord-Derived Mesenchymal Stromal Cells and Promote Lung Repair in Rat Bronchopulmonary Dysplasia
title_fullStr Human Platelet Lysate Maintains Stemness of Umbilical Cord-Derived Mesenchymal Stromal Cells and Promote Lung Repair in Rat Bronchopulmonary Dysplasia
title_full_unstemmed Human Platelet Lysate Maintains Stemness of Umbilical Cord-Derived Mesenchymal Stromal Cells and Promote Lung Repair in Rat Bronchopulmonary Dysplasia
title_sort human platelet lysate maintains stemness of umbilical cord-derived mesenchymal stromal cells and promote lung repair in rat bronchopulmonary dysplasia
publisher Frontiers Media S.A.
publishDate 2021
url https://doaj.org/article/fb120545559c4558ac642f985daec6df
work_keys_str_mv AT guilianliao humanplateletlysatemaintainsstemnessofumbilicalcordderivedmesenchymalstromalcellsandpromotelungrepairinratbronchopulmonarydysplasia
AT yanliao humanplateletlysatemaintainsstemnessofumbilicalcordderivedmesenchymalstromalcellsandpromotelungrepairinratbronchopulmonarydysplasia
AT duanduanli humanplateletlysatemaintainsstemnessofumbilicalcordderivedmesenchymalstromalcellsandpromotelungrepairinratbronchopulmonarydysplasia
AT zeqinfu humanplateletlysatemaintainsstemnessofumbilicalcordderivedmesenchymalstromalcellsandpromotelungrepairinratbronchopulmonarydysplasia
AT shiduowu humanplateletlysatemaintainsstemnessofumbilicalcordderivedmesenchymalstromalcellsandpromotelungrepairinratbronchopulmonarydysplasia
AT danlingcheng humanplateletlysatemaintainsstemnessofumbilicalcordderivedmesenchymalstromalcellsandpromotelungrepairinratbronchopulmonarydysplasia
AT qiuxingouyang humanplateletlysatemaintainsstemnessofumbilicalcordderivedmesenchymalstromalcellsandpromotelungrepairinratbronchopulmonarydysplasia
AT zantang humanplateletlysatemaintainsstemnessofumbilicalcordderivedmesenchymalstromalcellsandpromotelungrepairinratbronchopulmonarydysplasia
AT guifangzeng humanplateletlysatemaintainsstemnessofumbilicalcordderivedmesenchymalstromalcellsandpromotelungrepairinratbronchopulmonarydysplasia
AT xiaoliang humanplateletlysatemaintainsstemnessofumbilicalcordderivedmesenchymalstromalcellsandpromotelungrepairinratbronchopulmonarydysplasia
AT shaokunxu humanplateletlysatemaintainsstemnessofumbilicalcordderivedmesenchymalstromalcellsandpromotelungrepairinratbronchopulmonarydysplasia
AT junyuanhu humanplateletlysatemaintainsstemnessofumbilicalcordderivedmesenchymalstromalcellsandpromotelungrepairinratbronchopulmonarydysplasia
AT muyunliu humanplateletlysatemaintainsstemnessofumbilicalcordderivedmesenchymalstromalcellsandpromotelungrepairinratbronchopulmonarydysplasia
_version_ 1718440061813391360